全国动脉瘤治疗趋势:手术量上升、效率提高与外科医生报酬缩水
BACKGROUND: Over the past 2 decades, management of aortic, peripheral, and visceral artery aneurysms has been transformed by endovascular techniques, resulting in a growing number of treated patients. Despite this expansion, vascular surgeon reimbursement has steadily declined.…
要点
- 每例费用每年下降11.33美元,人均支出指数每年上升0.0263。
- Medicare报销缩水,临床产出与支付之间的脱节加剧。
核心结论
- 动脉瘤治疗规模扩大、效率提高且每例成本下降,但Medicare报销缩水,临床产出与支付脱节加剧。
研究设计与样本
- 分析2000至2021年医学支出面板调查和国民收入与产品账户的全国代表性数据,采用最小二乘回归评估趋势,并纳入2011-2021年Medicare报销数据。
主要发现
- 动脉瘤相关病例每年增加约41000例(P < 0.0001)。
- 每例费用每年下降11.33美元(P = 0.011)。
- 人均支出指数每年上升0.0263(P < 0.0001),医疗支出指数每年下降0.0039(P = 0.011)。
- 治疗患病率指数每年上升0.0335(P < 0.0001)。
临床怎么用
- 血管外科医生需关注动脉瘤治疗量增但每例费用下降和Medicare报销缩水的经济压力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Over the past 2 decades, management of aortic, peripheral, and visceral artery aneurysms has been transformed by endovascular techniques, resulting in a growing number of treated patients. Despite this expansion, vascular surgeon reimbursement has steadily declined. We evaluated national expenditure trends for aneurysm care relative to US gross domestic product and healthcare sector output to contextualize the evolving economic landscape facing vascular surgeons. METHODS: We analyzed nationally representative data from the Medical Expenditure Panel Survey and the National Income and Product Accounts from 2000 to 2021. Outcomes included annual aneurysm-related episodes, total expenditures, per capita spending, and cost per case. Trends were assessed using least squares regression. Expenditures were net of drug rebates and examined using indices of per capita spending and overall medical care expenditures. A derived prevalence index (treated prevalence = per capita index/medical care expenditure index) reflected changes in the proportion of patients treated over time. Medicare reimbursement data (2011-2021) were incorporated to provide surgeon-level payment context. RESULTS: From 2000 to 2021, aneurysm-related episodes increased by approximately 41,000 cases annually (P < 0.0001). Total expenditures rose by $98 million per year (P < 0.0001), while cost per case declined by $11.33 annually (P = 0.011). Per capita spending increased steadily (0.0263/year, P < 0.0001), whereas Medical Care Expenditure Index declined (-0.0039/year, P = 0.011). The prevalence index increased by 0.0335 per year (P < 0.0001). CONCLUSION: Aneurysm care has expanded with increasing efficiency and declining per-case costs. However, Medicare reimbursement has eroded, highlighting a growing disconnect between clinical productivity and Medicare payment.
引用
- Joshi P, Gupta A, Moser GW, et al. National Trends in Aneurysm Care: Rising Volumes, Greater Efficiency, and Shrinking Surgeon Reimbursement. Ann Vasc Surg. 2026. PMID: 42276370. doi:10.1016/j.avsg.2026.05.101
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。